Surrozen, Inc.
NASDAQ:SRZN
11.88 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Surrozen, Inc. |
Symbool | SRZN |
Munteenheid | USD |
Prijs | 11.88 |
Beurswaarde | 38,085,498 |
Dividendpercentage | 0% |
52-weken bereik | 4.5 - 16.19 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Craig C. Parker M.B.A. |
Website | https://www.surrozen.com |
An error occurred while fetching data.
Over Surrozen, Inc.
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)